Veeva Systems (NYSE:VEEV) Price Target Raised to $275.00

Veeva Systems (NYSE:VEEV) had its target price increased by Stifel Nicolaus from $230.00 to $275.00 in a report published on Monday,Benzinga reports. Stifel Nicolaus currently has a buy rating on the technology company’s stock.

Other analysts have also recently issued research reports about the stock. Weiss Ratings raised shares of Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, August 12th. Mizuho decreased their target price on shares of Veeva Systems from $295.00 to $270.00 and set an “outperform” rating on the stock in a research note on Thursday, June 4th. TD Cowen restated a “buy” rating on shares of Veeva Systems in a report on Thursday, June 4th. UBS Group reduced their target price on shares of Veeva Systems from $220.00 to $190.00 and set a “neutral” rating on the stock in a research note on Thursday, June 4th. Finally, Barclays cut their price target on shares of Veeva Systems from $250.00 to $235.00 and set an “overweight” rating for the company in a report on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Veeva Systems currently has a consensus rating of “Moderate Buy” and a consensus price target of $253.75.

Veeva Systems Trading Up 3.4%

NYSE:VEEV opened at $251.01 on Monday. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50. The stock has a 50 day moving average of $194.64 and a two-hundred day moving average of $181.16. The firm has a market cap of $40.77 billion, a P/E ratio of 44.74, a price-to-earnings-growth ratio of 1.04 and a beta of 0.92.

Veeva Systems (NYSE:VEEV) last announced its earnings results on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. The business had revenue of $882.95 million during the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The business’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.97 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. On average, research analysts forecast that Veeva Systems will post 6.65 earnings per share for the current year.

Insiders Place Their Bets

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the completion of the transaction, the insider owned 19,449 shares of the company’s stock, valued at $4,866,723.27. This trade represents a 64.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Veeva Systems

Several large investors have recently made changes to their positions in VEEV. SHP Wealth Management purchased a new position in shares of Veeva Systems during the 4th quarter worth approximately $26,000. Activest Wealth Management raised its position in Veeva Systems by 3,175.0% in the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 127 shares during the period. MV Capital Management Inc. purchased a new stake in Veeva Systems in the fourth quarter valued at approximately $30,000. Reflection Asset Management acquired a new position in Veeva Systems during the fourth quarter worth $32,000. Finally, BOK Financial Private Wealth Inc. acquired a new position in Veeva Systems during the fourth quarter worth $33,000. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Higher analyst targets support the stock: Barclays’ target implies further upside, and Stifel Nicolaus is also forecasting strong appreciation. The consensus rating remains “Moderate Buy,” with institutional ownership at approximately 88%. Barclays raises Veeva Systems price target Stifel Nicolaus forecasts appreciation
• Positive Sentiment: Upcoming earnings are a potential catalyst: Veeva is expected to report quarterly results on Wednesday. Its prior quarter beat estimates, delivering $2.24 in EPS versus a $2.14 consensus and $882.95 million in revenue versus an $857.73 million estimate. Veeva Systems expected earnings release
• Neutral Sentiment: Analyst views remain mixed: Several firms maintain bullish ratings, but earlier target reductions from Canaccord Genuity, BMO Capital Markets and Goldman Sachs indicate concerns about valuation and growth. The average target is near the current trading range, limiting the immediate upside implied by the broader consensus. Wall Street analysts on Veeva Systems
• Negative Sentiment: Growth concerns and insider selling remain risks: Veeva has underperformed the broader market amid softer demand and competition. In addition, insider Thomas Schwenger sold $9.0 million of shares under a pre-arranged Rule 10b5-1 plan, reducing his holdings by nearly 65%. Veeva Systems insider sale

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.